| ²é¿´: 2503 | »Ø¸´: 1 | ||||
jinkairui123Ìú³æ (ÕýʽдÊÖ)
|
[½»Á÷]
CRISPR´¥·¢µÄÄÚÔ´Oct4»òSox2»ùÒòλµãȾɫÖÊÖØËܼ¤»îϸ°ûÖØ±à³Ì ÒÑÓÐ1È˲ÎÓë
|
|
ÌâÄ¿£ºCRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency ÆÚ¿¯£ºCell stem cell Ó°ÏìÒò×Ó£º23.394 Ö÷Òª¼¼Êõ£ºCRISPR-dCas9-VP64¼¤»îϵͳ¡¢ÓÕµ¼ÐÔ¶àÄܸÉϸ°û¹¹½¨¡¢Ô´úϸ°ûÖÆ×÷¡¢iPS¼ø¶¨ Ñо¿±³¾° ÖÕÄ©·Ö»¯µÄ³ÉÌåϸ°ûÄæ·Ö»¯£¬ÐγɶàÄܸÉϸ°û״̬µÄ¹ý³Ì³ÆÎªÏ¸°ûÖØ±à³Ì£¨Cell reprogramming£©¡£ÔÚ2006Ä꣬ÈÕ±¾¿ÆÑ§¼ÒɽÖÐÉìÃÖ£¨Shinya Yamanaka£©·¢±íÓÕµ¼ÐÔ¶àÄܸÉϸ°û£¨iPS, induced pluripotent stem cells£©¹¹½¨¼¼Êõ£¬ÀûÓÃÄæ×ªÂ¼²¡¶¾£¬°ÑOSKM£¨OCT4, SOX2,KLF4 and C-myc£©ËÄÒò×ÓÔÚÌåϸ°ûÖнøÐ㬱í´ï£¬³É¹¦°ÑСÊóÅßÌ¥³ÉÏËάϸ°ûÓÕµ¼ÐγɶàÄܸÉϸ°û£¬¿ª±ÙÁËÒ»¸öȫеĸÉϸ°ûÑо¿ÁìÓò¡£Ëæ×ÅÑо¿µÄÉîÈ룬ÈËÆ¤·ô³ÉÏËάϸ°û¡¢TÁܰÍϸ°ûµÈÒ²±»³É¹¦ÓÕµ¼³É¶àÄܸÉϸ°û¡£¶øÕâЩ¶àÄܸÉϸ°ûÓ빩ÌåDNAÊDZ£³ÖÒ»Öµģ¬ÇÒÓзֻ¯³É¶àÖÖϸ°ûµÄDZÁ¦£¬Õ¹ÏÖ³ö·Ç³£¹ãÀ«µÄÁÙ´²Ó¦ÓÃǰ¾°¡£Èç°ÑÈËѪҺÖеÄTÁܰÍϸ°ûÄæ·Ö»¯ÐγɶàÄܸÉϸ°ûºó£¬µ±¶¨Ïò·Ö»¯¼¼Êõ³ÉÊìʱ£¬ iPSÄܱ»ÓÐÐò·Ö»¯³ÉÐèÒªµÄϸ°û£¬±ÈÈçÐļ¡Ï¸°û¡¢Éñ¾Ï¸°ûµÈ¡£ ȾɫÌåÉÏÖØÒªµÄ»ùÒòÆô¶¯×ÓλµãµÄ±í¹ÛÒÅ´«Ñ§±ä»¯£¬ÈçDNA¼×»ù»¯Ë®Æ½±ä»¯¡¢×éµ°°×ÒÒõ£»¯Ë®Æ½±ä»¯¡¢È¾É«ÖÊÖØËܵȣ¬¿ªÆôÖØÒª»ùÒòÈçOCT4, SOX2µÈµÄÄÚÔ´ÐÔ±í´ï£¬ÊÇiPSÓÕµ¼¹ý³ÌÖÐÖÁ¹ØÖØÒªµÄʼþ£¬Ö±½Ó¹ØÏµµ½ÓÕµ¼ÊÇ·ñ³É¹¦¡£ CRISPR-Cas9ϵͳ×÷ΪһÖÖÇ¿´óµÄ»ùÒò±à¼¹¤¾ß£¬ÏÖ½ñÒѹ㷺ÓÃÓÚ³£¹æµÄϸ°û»òÕ߸öÌåµÄ»ùÒòÇóý¡¢»ùÒòÇÃÈë¡¢µãÍ»±äÍâ¡£µ±CAS9µ°°×½øÐÐʧ»î¸ÄÔìÒÔ¼°½á¹¹ÓòÌí¼Óºó£¬µÃµ½CRISPR-dCas9-SunTag-VP64ϵͳ£¬ÔòÄÜʵÏÖÌØÒì»ùÒòת¼¼¤»î¡£CRISPR-dCas9ÄÚÔ´»ùÒò¼¤»î¼¼Êõ£¨SunTag Gene Activation£©£¬ÕýºÃÓëiPSÓÕµ¼¼¼ÊõÍêÃÀÆõºÏ£¬½â¾öÁ˼¤»îÄÚÔ´OSKMËÄ»ùÒòµÄÎÊÌ⣬´Ó¶øµ®ÉúÁËÐÂÐ͵ÄiPS¹¹½¨²ßÂÔ£¨¼ûͼ1£©¡£ ͼ1. ÀûÓÃCRIPR-dCas9»ùÒò¼¤»îϵͳµÄiPSÓÕµ¼²ßÂÔ Ñо¿ÄÚÈݼ°½á¹û 1. Éè¼Æ¶¨Î»ÓÚSox2ºÍOct4»ùÒòÆô¶¯×ÓÇøºÍOct4ÔöÇ¿×ÓÇøµÄsgRNA£¬ÀûÓÃCRISPR-dCas9-SunTag-VP64¶ÔSox2ºÍOct4½øÐм¤»î¡£ ±¾Ñо¿Ê×ÏÈÉè¼ÆÁËÏàÓ¦»ùÒò°Ð±êµÄSgRNA£¬Æô¶¯×ÓÇø»òÕßÔöÇ¿×ÓÇø°Ð±êλÖÿ¼ÂÇÒòËØ°üÀ¨£ºsgRNA°Ð±êλÖÃÓëÖØÒªµÄת¼Òò×Ó£¨OCT4¡¢SOX2¡¢NANOG£©½áºÏλµã¡¢×éµ°°×ÒÒõ£×ªÒÆÃ¸p300½áºÏλµãµÄ¾àÀ룬°Ð±êÇø¸½½ü×éµ°°×ÒÒõ£»¯·Ö²¼¡¢DNA¼×»ù»¯·Ö²¼µÈ¡£²¢ÒÔMEFϸ°ûΪ²ÄÁÏ£¬ÔÚRNAˮƽ¼ì²âÁ˲»Í¬sgRNA¶Ô°Ð±ê»ùÒòsox2ºÍoct4µÄ¼¤»îЧ¹û£¨Í¼2£©¡£ ![]() ͼ 2. MEFϸ°ûÖУ¬Sox2ºÍOct4»ùÒòÆô¶¯×ÓÇøºÍOct4ÔöÇ¿×ÓÇø²»Í¬sgRNAµÄת¼¼¤»îЧ¹ûÑé֤ʵÑé 2. CRISPR-dCas9-SunTag-VP64ϵͳ¶ÔÖØÒª»ùÒò½øÐÐÄÚÔ´¼¤»î£¬Äܳɹ¦»ñµÃiPS. Ëæºó£¬Í¬ÑùʹÓô˷½·¨£¬ÀûÓÃɸѡ³öÀ´18¸öÓÐЧsgRNA£¬·Ö±ð¼¤»î7¸öÖØÒª»ùÒò: Oct4, Sox2, Klf4, c-Myc, Nr5a2, Glis 1, Cebpa¡£½«MEFÀûÓò¡¶¾¸ÐȾ·½·¨½øÐÐ18 sgRNAµ¼Èëºó£¬ÓëdCas9-SunTag-VP64Ðγɸ´ºÏÌ壬¼¤»îÁËOG2-MEFÖÐÏàÓ¦ÄÚÔ´»ùÒòµÄ±í´ï£¬¾¹ý17ÌìµÄÓÕµ¼ºó£¬³É¹¦µÃµ½ÁËiPSϸ°û£¬²¢Îȶ¨´«´ú£¬ÇÒÏÔʾ³öÓëÅßÌ¥¸Éϸ°ûÏàͬµÄ¿Ë¡ÐÎ̬¡£Í¨¹ýÃâÒßÓ«¹âºÍQPCR£¬ÏÔʾµÃµ½µÄiPS±í´ïNanog, Sox2ºÍSSEA-1£¬Ïà¹Ø¸Éϸ°û»ùÒò±í´ïˮƽÓëRIÅßÌ¥¸Éϸ°ûÏà±È£¬¾ùÏ൱»òÕß³¬¹ý¡£´Ë²¿·ÖÖ¤Ã÷CRISPR-dCas9-SunTag-VP64ϵͳ½øÐÐÄÚÔ´¼¤»îʱ£¬Äܳɹ¦ÊµÏÖiPSÓÕµ¼£¨Í¼3£©¡£ ![]() ͼ3. CRISPR-dCas9-SunTag-VP64ϵͳͬʱ¼¤»îOct4, Sox2, Klf4, c-Myc, Nr5a2, Glis 1, CebpaÄÚÔ´±í´ïʱ£¬Äܳɹ¦ÊµÏÖiPSÓÕµ¼ 3. CRISPR-dCas9-SunTag-VP64ϵͳµ¥¶À¶ÔSox2»ùÒò½øÐÐÄÚÔ´¼¤»î£¬Ò²ÄÜÓÐЧ»ñµÃiPS Ñо¿Õßµ¥¶ÀѡȡÁËÄܶÔSox2½øÐ줻îµÄSgRNA½øÐÐiPSÓÕµ¼£¬·¢ÏÖÔÚÓÐЧ¼¤»îÄÚÔ´Sox2»ùÒò±í´ïµÄÇé¿öÏ£¬Äܳɹ¦µÃµ½ÓÕµ¼ÐÔ¶àÄܸÉϸ°û£¬²¢ÄÜÎȶ¨ÔöÖ³´«´ú¡£µÃµ½iPSͨ¹ýÌåÄÚÌåÍâʵÑ飬Èç¸Éϸ°û»ùÒò±í´ïÇé¿ö¼ì²âʵÑ飨ÃâÒßÓ«¹â¡¢qPCRµÈ£©¡¢ÄÒÅß×¢ÉäʵÑéµÈ£¬ÔÚÄÒÅß×¢ÉäʵÑéºó£¬»¹µÃµ½ÁËǶºÏÌåСÊ󣬲¢ÄÜÎȶ¨µØÉúÖ³´«µÝ£¬ºó´úÖеõ½OG2СÊóƷϵµÄСÊó¡£ÕâЩʵÑéÖ¤Ã÷ÁËiPSϸ°ûϵµÄÍêÕû¸ÉÐÔ£ºÎȶ¨×ÔÎÒ¸üÐÂÄÜÁ¦ºÍ¶àÏò·Ö»¯ÄÜÁ¦£¨Í¼4£©¡£ ͼ4. CRISPR-dCas9-SunTag-VP64ϵͳµ¥¶À¼¤»îSox2ÄÚÔ´±í´ïʱ£¬Äܳɹ¦ÊµÏÖiPSÓÕµ¼ 4. CRISPR-dCas9-SunTag-VP64ϵͳͬʱ¶ÔOct4»ùÒòÆô¶¯×ÓÇøºÍÔöÇ¿×ÓÇø½øÐÐÄÚÔ´¼¤»î£¬ÄÜÓÐЧ»ñµÃiPS ½ÓÏÂÀ´£¬Ñо¿Õßѡȡ°Ð±êλÖÃΪOct4Æô¶¯×ÓÇø»òÕßÔöÇ¿×ÓÇøµÄsgRNA½øÐÐÓÕµ¼ÊµÑ飬·¢ÏÖµ¥¶ÀÀûÓÃOct4Æô¶¯×ÓÇøµÄsgRNA»òÕßÔöÇ¿×ÓÇøsgRNA¶ÔOct4»ùÒò½øÐ줻îʱ£¬ËäÈ»±í´ï¼¤»î£¬µ«ÄÚÔ´Ç¿¶ÈÎÞ·¨µÃÓëÅßÌ¥¸Éϸ°ûϵR1Ïà±È¡£ÔÚÓÕµ¼¹ý³ÌÖУ¬µ¥¶ÀµÄsgRNAÎÞ·¨µÃµ½iPS¡£Oct4Æô¶¯×ÓÇøµÄsgRNA»òÕßÔöÇ¿×ÓÇøsgRNA½øÐÐ×éºÏʱ£¬ÄÚÔ´Oct4±í´ïÇ¿¶ÈµÃµ½Á˺ܺõÄÌáÉý£¬×îÖյõ½iPS£¬²¢ÄÜÎȶ¨ÔöÖ³´«´ú¡£µÃµ½iPSͨ¹ýÌåÄÚÌåÍâʵÑ飬Èç¸Éϸ°û»ùÒò±í´ïÇé¿ö¼ì²âʵÑ飨ÃâÒßÓ«¹â¡¢qPCRµÈ£©¡¢ÄÒÅß×¢ÉäʵÑéµÈ£¬ÔÚÄÒÅß×¢ÉäʵÑéºó£¬»¹µÃµ½ÁËǶºÏÌåСÊ󣬲¢ÄÜÎȶ¨µØÉúÖ³´«µÝ£¬ºó´úÖеõ½OG2СÊóƷϵµÄСÊó¡£ÕâЩʵÑéÖ¤Ã÷ÁËiPSϸ°ûϵµÄÍêÕû¸ÉÐÔ£ºÎȶ¨×ÔÎÒ¸üÐÂÄÜÁ¦ºÍ¶àÏò·Ö»¯ÄÜÁ¦£¨Í¼5£©¡£ ͼ 5. CRISPR-dCas9-SunTag-VP64ϵͳͬʱ¶ÔOct4»ùÒòÆô¶¯×ÓÇøºÍÔöÇ¿×ÓÇø½øÐÐÄÚÔ´¼¤»îÄÜÓÐЧ»ñµÃiPS ÎÄÕÂС½á ×÷ΪÀûÓÃCRISPR-dCas9¼¤»îϵͳ½øÐÐiPS¹¹½¨£¬×÷Õ߷dz£ÓÐÁ¦µØÖ¤Ã÷ÁËCRISPR-dCas9-SunTag-VP64ϵͳ¶Ô¹¹½¨iPSµÄÓÐЧÐÔ¡£¿ÉÒÔÔ¤¼û£¬ºóÐøµÄMEFÖ±½ÓÓÕµ¼ÐγÉÐļ¡Ï¸°û¡¢Éñ¾Ï¸°ûµÄÑо¿ÖУ¬´ËϵͳºÜ¿ÉÄÜÒ²ÓÐһϯ֮µØ¡£´ËÎÄÕ¼ȽøÐÐÁËÏà¹Ø¼¼Êõ·½·¨Ì½Ë÷£¬Ò²»Ø´ðÁËÒ»¸ö·Ç³£ºÃµÄ¿ÆÑ§ÎÊÌ⣺iPSÓÕµ¼¹ý³ÌÖУ¬Ïà¹ØÄÚÔ´»ùÒòµÄ±í¹ÛÒÅ´«Ñ§±ä»¯Ö±¹ÛÖØÒª¡£ ÔÚ±í¹ÛÒÅ´«Ñ§Ñо¿ÖУ¬CRIPSR-dCas9¼¤»îÄÚÔ´»ùÒò±í´ïµÄÓ¦Ó㬻áÏà¶Ô¹ã·ºÒ»Ð©¡£CRISPR-dCas9-SunTag-VP64ϵͳÉԼӸĽø£¬ºÜ¿ÉÄÜÊÇÖ±½Ó¸Ä±äÏà¹Ø»ùÒò±í¹ÛÒÅ´«Ñ§ÌØÕ÷µÄÀûÆ÷¡£ ½âÎöÎÄÏ× P. Liu, M. Chen, Y. Liu, L.S. Qi, S. Ding. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency, Cell stem cell, 22 (2018) 252-261. ²Î¿¼ÎÄÏ× 1. Black, J. B., Adler, A. F., et al. (2016) Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells. Cell stem cell 19, 406-414 2Chakraborty, S., Ji, H., Kabadi, A. M., et al. (2014) A CRISPR/Cas9-based system for reprogramming cell lineage specification. Stem cell reports 3, 940-947 3. Chavez, A., Scheiman, J., et al. (2015) Highly efficient Cas9-mediated transcriptional programming. Nature methods 12, 326-328 4. Thakore, P. I., D'Ippolito, A. M., et al. (2015) Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature methods 12, 1143-1149 5. Buganim, Y., Faddah, D. A., et al. (2012) Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222 6.Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
crispr-cas9 Ïà¹Ø×ÊÁÏ |
» ²ÂÄãϲ»¶
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ºÊµÑéÆ÷²ÄµÄ ¡°ÎÚÁú¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖеÄȤÊ£ººÍʵÑé²ÄÁ쵀 ¡°¶·ÖǶ·Ó¡±
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ79È˻ظ´
µ°°×Öʼì²â£º¾«×¼·ÖÎö£¬½âËøÉúÎï·Ö×ÓµÄÃÜÂë
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑé֮СÊóʵÑ飺ÑϽ÷Éè¼Æ£¬½âÎöÉúÃü»úÖÆµÄÖØÒªÔØÌå
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®ÖØ½ðÊô¼ì²â£º¾«×¼É¸²é£¬ÊØ»¤½¡¿µÓë»·¾³µÄ·ÀÏß
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÍܲâÖØ½ðÊôÎÒ±³¹øÈýǧ¡±
ÒѾÓÐ0È˻ظ´
²»ºÏÀíÍÜ¿ÆÑÐʵÑéÖ®¡°ÊóÌÓÈý´ÎÎÒ·¢ÈýƪSCI¡±
ÒѾÓÐ0È˻ظ´
ÄÉÃ×Á£¶È·ÖÎö
ÒѾÓÐ3È˻ظ´
ÁÖ¿ÆÔºÁÖ»¯ËùÕÐÊÕ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿£¬×ø±êÄϾ©
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

xjjf
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 347.4
- Ìû×Ó: 28
- ÔÚÏß: 14.2Сʱ
- ³æºÅ: 22017298
- ×¢²á: 2020-04-29
- רҵ: Ë®²úÉúÎïÒÅ´«ÓýÖÖѧ
2Â¥2021-07-31 23:50:57


















»Ø¸´´ËÂ¥
